Evidence of significant apoptosis in poorly differentiated ductal carcinoma in situ of the breast
1998

Apoptosis in Ductal Carcinoma In Situ of the Breast

Sample size: 58 publication Evidence: high

Author Information

Author(s): A Gandhi, PA Holland, WF Knox, CS Potten, NJ Bundred

Primary Institution: University Hospital of South Manchester

Hypothesis

The study aims to evaluate the presence and distribution of apoptosis in ductal carcinoma in situ (DCIS) to investigate its role in the development of invasive cancer.

Conclusion

Apoptosis significantly contributes to cell death in high-grade, ER-negative ductal carcinoma in situ, which is associated with a higher risk of recurrence and progression to invasive cancer.

Supporting Evidence

  • Apoptotic index was significantly higher in comedo DCIS compared to non-comedo types.
  • High apoptotic rates were associated with high nuclear grade and negative ER status.
  • Bcl-2 expression was inversely correlated with the apoptotic index.

Takeaway

The study found that a type of breast cancer called ductal carcinoma in situ has a lot of cell death happening, which is important for understanding how it might turn into more serious cancer.

Methodology

The study analyzed 58 samples of DCIS using light microscopy to assess the apoptotic index and correlated it with various histological and biological parameters.

Limitations

The study is limited to archival samples and may not represent current treatment outcomes or patient demographics.

Participant Demographics

Median age of participants was 53 years, with a range from 26 to 75 years.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication